NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.
about
Novel Immunotherapies for Multiple Myeloma.Reconstructing the immune system with lentiviral vectors.Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.Ex vivo and in vivo genome editing: a regulatory scientific framework from early development to clinical implementation.Treating hematological malignancies with cell therapy: where are we now?Current Status of Gene Engineering Cell Therapeutics.
P2860
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
NY-ESO-1 TCR single edited ste ...... out graft-versus-host disease.
@en
type
label
NY-ESO-1 TCR single edited ste ...... out graft-versus-host disease.
@en
prefLabel
NY-ESO-1 TCR single edited ste ...... out graft-versus-host disease.
@en
P2093
P50
P1433
P1476
NY-ESO-1 TCR single edited ste ...... hout graft-versus-host disease
@en
P2093
Andreas Reik
Angelo Lombardo
Attilio Bondanza
Barbara Camisa
Elena Provasi
Eliana Ruggiero
Elisa Landoni
Fabio Ciceri
Giacomo Oliveira
Martina Rocchi
P304
P356
10.1182/BLOOD-2016-08-732636
P407
P50
P577
2017-06-21T00:00:00Z